Virtu KCG Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Virtu KCG Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-15,881	Closed	-$1.1M	–	3577
2017 Q1	$1.1M	Buy	+15,881	New	+$1.07M	0.03%	639
2016 Q3	–	Sell	-73,642	Closed	-$3.98M	–	3523
2016 Q2	$3.98M	Buy	73,642 +39,377	+115%	+$2.16M	0.08%	125
2016 Q1	$1.77M	Buy	34,265 +7,438	+28%	+$386K	0.05%	317
2015 Q4	$1.88M	Sell	26,827 -10,657	-28%	-$727K	0.03%	447
2015 Q3	$2.33M	Buy	37,484 +30,698	+452%	+$2.42M	0.04%	365
2015 Q2	$571K	Sell	6,786 -324	-5%	-$25.2K	0.01%	1368
2015 Q1	$534K	Sell	7,110 -8,283	-54%	-$579K	0.01%	1307
2014 Q4	$957K	Buy	+15,393	New	+$878K	0.02%	986
2014 Q3	–	Sell	-12,183	Closed	-$626K	–	4122
2014 Q2	$626K	Sell	12,183 -10,908	-47%	-$492K	0.01%	1698
2014 Q1	$1.1M	Sell	23,091 -22,602	-49%	-$1.16M	0.01%	1154
2013 Q4	$1.98M	Buy	45,693 +27,744	+155%	+$1.15M	0.02%	676
2013 Q3	$773K	Buy	+17,949	New	+$727K	0.01%	1467

Other funds holding XBI

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

QIM

Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Virtu KCG Holdings's XBI Position: Q2 2017 in Review

Virtu KCG Holdings sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2017, closing a stake of 15,881 shares — an estimated $1.1M sold.

Virtu KCG Holdings first reported a position in XBI in Q3 2013 and held it in 12 quarters. The position peaked at $3.98M in Q2 2016. 314 funds tracked by Wall St. Rank hold XBI as of Q2 2017.

Virtu KCG Holdings reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2017 after selling out during the quarter.
Virtu KCG Holdings sold 15,881 State Street SPDR S&P Biotech ETF shares in Q2 2017, an estimated $1.1M.
Virtu KCG Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q3 2013 and held it in 12 quarters.
Virtu KCG Holdings's State Street SPDR S&P Biotech ETF position peaked at $3.98M in Q2 2016.
314 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.